Increased evidence indicates that bone-derived transforming growth factor-beta (TGF-β1) and IL-1B can reactivate dormant disseminated tumour cells (DTCs) stimulating metastatic outgrowth in the bone [26]. The gene discussed is IL1B; the disease is neoplasm.